Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, has created a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.   The new center will focus on supporting the clinical trials of clients who are developing cell and gene therapies around the world and across multiple therapeutic areas, including hematology, oncology, cardiology and ophthalmology, as we...